cerebellar purkinje cell
Recently Published Documents


TOTAL DOCUMENTS

176
(FIVE YEARS 11)

H-INDEX

39
(FIVE YEARS 3)

2020 ◽  
pp. 101939
Author(s):  
Yael Pewzner-Jung ◽  
Tammar Joseph ◽  
Shani Blumenreich ◽  
Ayelet Vardi ◽  
Natalia Santos Ferreira ◽  
...  

2020 ◽  
Author(s):  
Skyler L Jackman ◽  
Christopher H Chen ◽  
Heather L Offermann ◽  
Iain R Drew ◽  
Bailey M Harrison ◽  
...  

2019 ◽  
Vol 13 ◽  
Author(s):  
Xinyu Hao ◽  
Shuangming Yang ◽  
Jiang Wang ◽  
Bin Deng ◽  
Xile Wei ◽  
...  

2019 ◽  
Vol 320 ◽  
pp. 112983 ◽  
Author(s):  
Jeong Hwi Cho ◽  
Hyun-Jin Tae ◽  
In-Shik Kim ◽  
Minah Song ◽  
Hyunjung Kim ◽  
...  

2019 ◽  
Author(s):  
Amanda M Brown ◽  
Joshua J White ◽  
Meike E van der Heijden ◽  
Tao Lin ◽  
Roy V Sillitoe

AbstractTremor is currently ranked as the most common movement disorder. The brain regions and neural signals that initiate the debilitating shakiness of different body parts remain unclear. Here, we found that genetically silencing cerebellar Purkinje cell activity blocked tremor in mice that were given the tremorgenic drug harmaline. We show in awake behaving mice that the onset of tremor is coincident with rhythmic Purkinje cell firing, which alters the output of their target cerebellar nuclei cells. We mimic the tremorgenic action of the drug with optogenetics and present evidence that highly patterned Purkinje cell activity drives a powerful tremor in otherwise normal mice. Modulating the altered activity with deep brain stimulation directed to the Purkinje cell output in the cerebellar nuclei reduced tremor in freely moving mice. Together, the data implicate Purkinje cell connectivity as a neural substrate for tremor and a gateway for signals that mediate the disease.


2019 ◽  
Vol 39 (32) ◽  
pp. 6339-6353 ◽  
Author(s):  
Nobutake Hosoi ◽  
Koji Shibasaki ◽  
Mayu Hosono ◽  
Ayumu Konno ◽  
Yo Shinoda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document